Mabvinra 40mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Adalimumab (40mg/0.8ml)
Overview Mabvinra 40mg Injection
Injexia 40mg is a therapeutic agent indicated for diverse inflammatory conditions including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. It alleviates associated inflammation, pain, and erythema, enhancing physical capabilities. Administration is exclusively by a qualified medical professional; self-injection is strictly prohibited. Consistent, daily dosing is crucial for optimal therapeutic response. Continue treatment as prescribed, completing the entire course even with symptom improvement. Commonly reported adverse effects include cephalalgia, sinusitis, cutaneous eruptions, upper respiratory infections, and localized injection site reactions (pain, redness, swelling). Persistent or worsening side effects warrant immediate physician consultation; management strategies may be implemented to mitigate these issues. Prior to commencing treatment, disclose any pre-existing cardiac, renal, or hepatic dysfunction, as well as all concurrent medications. Pregnant or lactating individuals should seek medical counsel before initiating Injexia 40mg therapy.
Uses of Mabvinra 40mg Injection
Spondyloarthropathy|Inflammatory joint disease|Psoriatic arthritis|Inflammatory bowel disease|Chronic inflammatory bowel disease
Major Benefits of Mabvinra 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mabvinra 40mg Injection:
- Headache
- Sinus inflammation
- Rash
- Upper respiratory tract infection
- Injection site reaction
How to use Mabvinra 40mg Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
How Mabvinra 40mg Injection works:
Mabvinra 40mg Injection inhibits the activity of specific inflammatory mediators, thus alleviating the swelling, redness, and inflammation characteristic of some arthritic conditions.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Mabvinra 40mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Mabvinra, 40mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Mabvinra 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving may be impaired by Mabvinra 40mg Injection side effects, such as dizziness and blurred vision. These effects can impact your ability to operate a vehicle.
KidneyCONSULT YOUR DOCTOR
Data on Mabvinra 40mg Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Mabvinra 40mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Mabvinra 40mg Injection :
Should you forget a scheduled dose of Mabvinra 40mg Injection, contact your physician for guidance.
Facts to Know About Mabvinra 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs) |
3,018 People bought this recently